A recent @jama.com study shows that the introduction of immunotherapy in individuals with newly-diagnosed cancers widens the survival inequity between privately insured and uninsured patients.
Read more by Zhao et al.: tinyurl.com/mu6zbhv9
A recent @jama.com study shows that the introduction of immunotherapy in individuals with newly-diagnosed cancers widens the survival inequity between privately insured and uninsured patients.
Read more by Zhao et al.: tinyurl.com/mu6zbhv9